Select Page

FW: Burkholderia cepacia contamination of skin prep.

Home Forums Infexion Connexion FW: Burkholderia cepacia contamination of skin prep.

 | Click to Receive Email Notifications of Posts
Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • #75677
    Anonymous
    Inactive

    Author:
    Anonymous

    Organisation:

    State:

    Hi Michael

    Dr Chris Blyth asked me if I could get this posted on ACIPC discussion list

    Many thanks

    Rebecca
    Rebecca McCann | Program Manager | Healthcare Associated Infection Unit (HAIU)
    Communicable Disease Control Directorate
    Department of Health

    T: 08 9222 2043 M: 0439 920 819 E: rebecca.mccann@health.wa.gov.au

    From: Christopher Blyth [mailto:christopher.blyth@uwa.edu.au]
    Sent: Monday, 5 August 2019 4:09 PM
    To: ozbug@asid.net.au
    Subject: [ozbug] Burkholderia cepacia contamination of skin prep.

    Dear all

    I am keen to alert you to an emerging concern we have seen in our hospital.

    Case: we have a neonate with severe scalp infection secondary to Burkholderia cepacia.

    Investigation: given the unusual nature of this organism in this population, we have looked for environmental sources. The wound followed an EEG – the scalp was prepared with an abrasive skin prepping lotion.

    Lemon Prep
    Product Code MD0019
    Supplier Address Mavidon Medical Products 6625 White Dr Riviera Beach, FL 33407 USA

    This is a multiuse produce supplied in 114gm tubes.

    We have tested a number of these and identified B cepecia in both open and unopened tubes. Clonality has not yet been determined. Other pathogens have not been identified in the prep.

    The lot numbers that are positive (so far) are 30145, 29824, 30006 and 30236.

    This abrasive preparation is used to prepare the skin, reducing the skin impedance.

    The TGA and the manufacturer have been notified.

    We are using alternative products pending further investigation.

    My understanding is that this skin prep is used extensively throughout Australia and the extent of the contamination is not yet known. Could you please inform your infection prevention and neurology colleagues

    Best wishes

    Chris

    Dr Christopher Blyth MBBS(Hons), DCH, FRACP, FRCPA, PhD

    Paediatrician, Infectious Diseases Physician and Clinical Microbiologist.

    Associate Professor | Division of Paediatrics, School of Medicine, Faculty of Health and Medical Sciences, The University of Western Australia
    Head of Department | Department of Infectious Diseases, Perth Childrens Hospital
    Clinical Microbiologist | Department of Microbiology, PathWest Laboratory Medicine WA, QEII Medical Centre
    Co-Director | Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute
    NHMRC Career Development Fellow | National Health and Medical Research Council

    P: GPO Box D184, Perth, Western Australia 6840
    T: +61 8 6456 5614 | M: +61 418827009 | E: christopher.blyth@uwa.edu.au

    Compassion | Collaboration | Equity | Respect | Excellence | Accountability

    [PCH_RGB_VERT_INTERNAL][The University of Western Australia][cid:image001.jpg@01D42796.30539A30][http://delta.ichr.uwa.edu.au/Telethon_Kids_Logo_128.jpg]


    You received this message because you are subscribed to the Google Groups “Ozbug” group.
    To unsubscribe from this group and stop receiving emails from it, send an email to ozbug+unsubscribe@asid.net.au.
    To view this discussion on the web visit https://groups.google.com/a/asid.net.au/d/msgid/ozbug/SYBPR01MB5275615EA52221DF0D2FA213CBDA0%40SYBPR01MB5275.ausprd01.prod.outlook.com.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.

    #75684
    Michael Wishart
    Participant

    Author:
    Michael Wishart

    Email:
    Michael.Wishart@svha.org.au

    Organisation:

    State:
    NSW

    Hi all

    Please see the attached urgent quarantine notice from TGA regarding this product.

    Thanks
    Michael

    Michael Wishart | Infection Control Coordinator, CICP-E

    St Vincents Private Hospital Northside | 627 Rode Road CHERMSIDE QLD 4032
    T +61 7 3326 3068 | F +61 7 3607 2226
    E michael.wishart@svha.org.au |
    W https://www.svphn.org.au

    [cid:image001.jpg@01D46C86.4CDB6090]
    [2019 conference email signature]

    From: ACIPC Infexion Connexion [mailto:ACIPCLIST@ACIPC.ORG.AU] On Behalf Of McCann, Rebecca
    Sent: Monday, 5 August 2019 6:16 PM
    To: ACIPCLIST@ACIPC.ORG.AU
    Subject: [ACIPC_Infexion_Connexion] FW: Burkholderia cepacia contamination of skin prep.

    Hi Michael

    Dr Chris Blyth asked me if I could get this posted on ACIPC discussion list

    Many thanks

    Rebecca
    Rebecca McCann | Program Manager | Healthcare Associated Infection Unit (HAIU)
    Communicable Disease Control Directorate
    Department of Health

    T: 08 9222 2043 M: 0439 920 819 E: rebecca.mccann@health.wa.gov.au

    From: Christopher Blyth [mailto:christopher.blyth@uwa.edu.au]
    Sent: Monday, 5 August 2019 4:09 PM
    To: ozbug@asid.net.au
    Subject: [ozbug] Burkholderia cepacia contamination of skin prep.

    Dear all

    I am keen to alert you to an emerging concern we have seen in our hospital.

    Case: we have a neonate with severe scalp infection secondary to Burkholderia cepacia.

    Investigation: given the unusual nature of this organism in this population, we have looked for environmental sources. The wound followed an EEG – the scalp was prepared with an abrasive skin prepping lotion.

    Lemon Prep
    Product Code MD0019
    Supplier Address Mavidon Medical Products 6625 White Dr Riviera Beach, FL 33407 USA

    This is a multiuse produce supplied in 114gm tubes.

    We have tested a number of these and identified B cepecia in both open and unopened tubes. Clonality has not yet been determined. Other pathogens have not been identified in the prep.

    The lot numbers that are positive (so far) are 30145, 29824, 30006 and 30236.

    This abrasive preparation is used to prepare the skin, reducing the skin impedance.

    The TGA and the manufacturer have been notified.

    We are using alternative products pending further investigation.

    My understanding is that this skin prep is used extensively throughout Australia and the extent of the contamination is not yet known. Could you please inform your infection prevention and neurology colleagues

    Best wishes

    Chris

    Dr Christopher Blyth MBBS(Hons), DCH, FRACP, FRCPA, PhD

    Paediatrician, Infectious Diseases Physician and Clinical Microbiologist.

    Associate Professor | Division of Paediatrics, School of Medicine, Faculty of Health and Medical Sciences, The University of Western Australia
    Head of Department | Department of Infectious Diseases, Perth Childrens Hospital
    Clinical Microbiologist | Department of Microbiology, PathWest Laboratory Medicine WA, QEII Medical Centre
    Co-Director | Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute
    NHMRC Career Development Fellow | National Health and Medical Research Council

    P: GPO Box D184, Perth, Western Australia 6840
    T: +61 8 6456 5614 | M: +61 418827009 | E: christopher.blyth@uwa.edu.au

    Compassion | Collaboration | Equity | Respect | Excellence | Accountability

    [PCH_RGB_VERT_INTERNAL][The University of Western Australia][cid:image001.jpg@01D42796.30539A30][http://delta.ichr.uwa.edu.au/Telethon_Kids_Logo_128.jpg]


    You received this message because you are subscribed to the Google Groups “Ozbug” group.
    To unsubscribe from this group and stop receiving emails from it, send an email to ozbug+unsubscribe@asid.net.au.
    To view this discussion on the web visit https://groups.google.com/a/asid.net.au/d/msgid/ozbug/SYBPR01MB5275615EA52221DF0D2FA213CBDA0%40SYBPR01MB5275.ausprd01.prod.outlook.com.

    ______________________________________________________________________
    This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return https://clicktime.symantec.com/3nTAGvKeyxKE8LS4k1exoS7Vc?u=email%2C%20delete%20the%20Email%2C%20and%20do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

    ______________________________________________________________________
    This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

    To send a message to the list administrator send an email to admin@acipc.org.au

    You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

Viewing 2 posts - 1 through 2 (of 2 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.